Current File : /var/www/html/rental/storage/jslabjdg/cache/623ea96b2fa4cc20661b36c85d23822f
a:5:{s:8:"template";s:15011:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible">
<meta content="text/html; charset=utf-8" http-equiv="Content-Type">
<meta content="width=device-width, initial-scale=1, maximum-scale=1" name="viewport">
<title>{{ keyword }}</title>
<style rel="stylesheet" type="text/css">.wc-block-product-categories__button:not(:disabled):not([aria-disabled=true]):hover{background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #e2e4e7,inset 0 0 0 2px #fff,0 1px 1px rgba(25,30,35,.2)}.wc-block-product-categories__button:not(:disabled):not([aria-disabled=true]):active{outline:0;background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #ccd0d4,inset 0 0 0 2px #fff}.wc-block-product-search .wc-block-product-search__button:not(:disabled):not([aria-disabled=true]):hover{background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #e2e4e7,inset 0 0 0 2px #fff,0 1px 1px rgba(25,30,35,.2)}.wc-block-product-search .wc-block-product-search__button:not(:disabled):not([aria-disabled=true]):active{outline:0;background-color:#fff;color:#191e23;box-shadow:inset 0 0 0 1px #ccd0d4,inset 0 0 0 2px #fff} *{box-sizing:border-box}.fusion-clearfix{clear:both;zoom:1}.fusion-clearfix:after,.fusion-clearfix:before{content:" ";display:table}.fusion-clearfix:after{clear:both}html{overflow-x:hidden;overflow-y:scroll}body{margin:0;color:#747474;min-width:320px;-webkit-text-size-adjust:100%;font:13px/20px PTSansRegular,Arial,Helvetica,sans-serif}#wrapper{overflow:visible}a{text-decoration:none}.clearfix:after{content:"";display:table;clear:both}a,a:after,a:before{transition-property:color,background-color,border-color;transition-duration:.2s;transition-timing-function:linear}#main{padding:55px 10px 45px;clear:both}.fusion-row{margin:0 auto;zoom:1}.fusion-row:after,.fusion-row:before{content:" ";display:table}.fusion-row:after{clear:both}.fusion-columns{margin:0 -15px}footer,header,main,nav,section{display:block}.fusion-header-wrapper{position:relative;z-index:10010}.fusion-header-sticky-height{display:none}.fusion-header{padding-left:30px;padding-right:30px;-webkit-backface-visibility:hidden;backface-visibility:hidden;transition:background-color .25s ease-in-out}.fusion-logo{display:block;float:left;max-width:100%;zoom:1}.fusion-logo:after,.fusion-logo:before{content:" ";display:table}.fusion-logo:after{clear:both}.fusion-logo a{display:block;max-width:100%}.fusion-main-menu{float:right;position:relative;z-index:200;overflow:hidden}.fusion-header-v1 .fusion-main-menu:hover{overflow:visible}.fusion-main-menu>ul>li:last-child{padding-right:0}.fusion-main-menu ul{list-style:none;margin:0;padding:0}.fusion-main-menu ul a{display:block;box-sizing:content-box}.fusion-main-menu li{float:left;margin:0;padding:0;position:relative;cursor:pointer}.fusion-main-menu>ul>li{padding-right:45px}.fusion-main-menu>ul>li>a{display:-ms-flexbox;display:flex;-ms-flex-align:center;align-items:center;line-height:1;-webkit-font-smoothing:subpixel-antialiased}.fusion-main-menu .fusion-dropdown-menu{overflow:hidden}.fusion-caret{margin-left:9px}.fusion-mobile-menu-design-modern .fusion-header>.fusion-row{position:relative}body:not(.fusion-header-layout-v6) .fusion-header{-webkit-transform:translate3d(0,0,0);-moz-transform:none}.fusion-footer-widget-area{overflow:hidden;position:relative;padding:43px 10px 40px;border-top:12px solid #e9eaee;background:#363839;color:#8c8989;-webkit-backface-visibility:hidden;backface-visibility:hidden}.fusion-footer-widget-area .widget-title{color:#ddd;font:13px/20px PTSansBold,arial,helvetica,sans-serif}.fusion-footer-widget-area .widget-title{margin:0 0 28px;text-transform:uppercase}.fusion-footer-widget-column{margin-bottom:50px}.fusion-footer-widget-column:last-child{margin-bottom:0}.fusion-footer-copyright-area{z-index:10;position:relative;padding:18px 10px 12px;border-top:1px solid #4b4c4d;background:#282a2b}.fusion-copyright-content{display:table;width:100%}.fusion-copyright-notice{display:table-cell;vertical-align:middle;margin:0;padding:0;color:#8c8989;font-size:12px}.fusion-body p.has-drop-cap:not(:focus):first-letter{font-size:5.5em}p.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal}:root{--button_padding:11px 23px;--button_font_size:13px;--button_line_height:16px}@font-face{font-display:block;font-family:'Antic Slab';font-style:normal;font-weight:400;src:local('Antic Slab Regular'),local('AnticSlab-Regular'),url(https://fonts.gstatic.com/s/anticslab/v8/bWt97fPFfRzkCa9Jlp6IacVcWQ.ttf) format('truetype')}@font-face{font-display:block;font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(https://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFVZ0e.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:italic;font-weight:400;src:local('PT Sans Italic'),local('PTSans-Italic'),url(https://fonts.gstatic.com/s/ptsans/v11/jizYRExUiTo99u79D0e0x8mN.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:italic;font-weight:700;src:local('PT Sans Bold Italic'),local('PTSans-BoldItalic'),url(https://fonts.gstatic.com/s/ptsans/v11/jizdRExUiTo99u79D0e8fOydLxUY.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:normal;font-weight:400;src:local('PT Sans'),local('PTSans-Regular'),url(https://fonts.gstatic.com/s/ptsans/v11/jizaRExUiTo99u79D0KEwA.ttf) format('truetype')}@font-face{font-display:block;font-family:'PT Sans';font-style:normal;font-weight:700;src:local('PT Sans Bold'),local('PTSans-Bold'),url(https://fonts.gstatic.com/s/ptsans/v11/jizfRExUiTo99u79B_mh0O6tKA.ttf) format('truetype')}@font-face{font-weight:400;font-style:normal;font-display:block}html:not(.avada-html-layout-boxed):not(.avada-html-layout-framed),html:not(.avada-html-layout-boxed):not(.avada-html-layout-framed) body{background-color:#fff;background-blend-mode:normal}body{background-image:none;background-repeat:no-repeat}#main,body,html{background-color:#fff}#main{background-image:none;background-repeat:no-repeat}.fusion-header-wrapper .fusion-row{padding-left:0;padding-right:0}.fusion-header .fusion-row{padding-top:0;padding-bottom:0}a:hover{color:#74a6b6}.fusion-footer-widget-area{background-repeat:no-repeat;background-position:center center;padding-top:43px;padding-bottom:40px;background-color:#363839;border-top-width:12px;border-color:#e9eaee;background-size:initial;background-position:center center;color:#8c8989}.fusion-footer-widget-area>.fusion-row{padding-left:0;padding-right:0}.fusion-footer-copyright-area{padding-top:18px;padding-bottom:16px;background-color:#282a2b;border-top-width:1px;border-color:#4b4c4d}.fusion-footer-copyright-area>.fusion-row{padding-left:0;padding-right:0}.fusion-footer footer .fusion-row .fusion-columns{display:block;-ms-flex-flow:wrap;flex-flow:wrap}.fusion-footer footer .fusion-columns{margin:0 calc((15px) * -1)}.fusion-footer footer .fusion-columns .fusion-column{padding-left:15px;padding-right:15px}.fusion-footer-widget-area .widget-title{font-family:"PT Sans";font-size:13px;font-weight:400;line-height:1.5;letter-spacing:0;font-style:normal;color:#ddd}.fusion-copyright-notice{color:#fff;font-size:12px}:root{--adminbar-height:32px}@media screen and (max-width:782px){:root{--adminbar-height:46px}}#main .fusion-row,.fusion-footer-copyright-area .fusion-row,.fusion-footer-widget-area .fusion-row,.fusion-header-wrapper .fusion-row{max-width:1100px}html:not(.avada-has-site-width-percent) #main,html:not(.avada-has-site-width-percent) .fusion-footer-copyright-area,html:not(.avada-has-site-width-percent) .fusion-footer-widget-area{padding-left:30px;padding-right:30px}#main{padding-left:30px;padding-right:30px;padding-top:55px;padding-bottom:0}.fusion-sides-frame{display:none}.fusion-header .fusion-logo{margin:31px 0 31px 0}.fusion-main-menu>ul>li{padding-right:30px}.fusion-main-menu>ul>li>a{border-color:transparent}.fusion-main-menu>ul>li>a:not(.fusion-logo-link):not(.fusion-icon-sliding-bar):hover{border-color:#74a6b6}.fusion-main-menu>ul>li>a:not(.fusion-logo-link):hover{color:#74a6b6}body:not(.fusion-header-layout-v6) .fusion-main-menu>ul>li>a{height:84px}.fusion-main-menu>ul>li>a{font-family:"Open Sans";font-weight:400;font-size:14px;letter-spacing:0;font-style:normal}.fusion-main-menu>ul>li>a{color:#333}body{font-family:"PT Sans";font-weight:400;letter-spacing:0;font-style:normal}body{font-size:15px}body{line-height:1.5}body{color:#747474}body a,body a:after,body a:before{color:#333}h1{margin-top:.67em;margin-bottom:.67em}.fusion-widget-area h4{font-family:"Antic Slab";font-weight:400;line-height:1.5;letter-spacing:0;font-style:normal}.fusion-widget-area h4{font-size:13px}.fusion-widget-area h4{color:#333}h4{margin-top:1.33em;margin-bottom:1.33em}body:not(:-moz-handler-blocked) .avada-myaccount-data .addresses .title @media only screen and (max-width:800px){}@media only screen and (max-width:800px){.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-header{padding-top:20px;padding-bottom:20px}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-header .fusion-row{width:100%}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-logo{margin:0!important}.fusion-header .fusion-row{padding-left:0;padding-right:0}.fusion-header-wrapper .fusion-row{padding-left:0;padding-right:0;max-width:100%}.fusion-footer-copyright-area>.fusion-row,.fusion-footer-widget-area>.fusion-row{padding-left:0;padding-right:0}.fusion-mobile-menu-design-modern.fusion-header-v1 .fusion-main-menu{display:none}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:portrait){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-column{margin-right:0}#wrapper{width:auto!important}.fusion-columns-4 .fusion-column{width:50%!important;float:left!important}.fusion-columns-4 .fusion-column:nth-of-type(2n+1){clear:both}#footer>.fusion-row,.fusion-header .fusion-row{padding-left:0!important;padding-right:0!important}#main,.fusion-footer-widget-area,body{background-attachment:scroll!important}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:landscape){#main,.fusion-footer-widget-area,body{background-attachment:scroll!important}}@media only screen and (max-width:800px){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-columns .fusion-column{width:100%!important;float:none;box-sizing:border-box}.fusion-columns .fusion-column:not(.fusion-column-last){margin:0 0 50px}#wrapper{width:auto!important}.fusion-copyright-notice{display:block;text-align:center}.fusion-copyright-notice{padding:0 0 15px}.fusion-copyright-notice:after{content:"";display:block;clear:both}.fusion-footer footer .fusion-row .fusion-columns .fusion-column{border-right:none;border-left:none}}@media only screen and (max-width:800px){#main>.fusion-row{display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;flex-wrap:wrap}}@media only screen and (max-width:640px){#main,body{background-attachment:scroll!important}}@media only screen and (max-device-width:640px){#wrapper{width:auto!important;overflow-x:hidden!important}.fusion-columns .fusion-column{float:none;width:100%!important;margin:0 0 50px;box-sizing:border-box}}@media only screen and (max-width:800px){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-columns .fusion-column{width:100%!important;float:none;-webkit-box-sizing:border-box;box-sizing:border-box}.fusion-columns .fusion-column:not(.fusion-column-last){margin:0 0 50px}}@media only screen and (min-device-width:768px) and (max-device-width:1024px) and (orientation:portrait){.fusion-columns-4 .fusion-column:first-child{margin-left:0}.fusion-column{margin-right:0}.fusion-columns-4 .fusion-column{width:50%!important;float:left!important}.fusion-columns-4 .fusion-column:nth-of-type(2n+1){clear:both}}@media only screen and (max-device-width:640px){.fusion-columns .fusion-column{float:none;width:100%!important;margin:0 0 50px;-webkit-box-sizing:border-box;box-sizing:border-box}}</style>
</head>
<body>
<div id="boxed-wrapper">
<div class="fusion-sides-frame"></div>
<div class="fusion-wrapper" id="wrapper">
<div id="home" style="position:relative;top:-1px;"></div>
<header class="fusion-header-wrapper">
<div class="fusion-header-v1 fusion-logo-alignment fusion-logo-left fusion-sticky-menu- fusion-sticky-logo-1 fusion-mobile-logo-1 fusion-mobile-menu-design-modern">
<div class="fusion-header-sticky-height"></div>
<div class="fusion-header">
<div class="fusion-row">
<div class="fusion-logo" data-margin-bottom="31px" data-margin-left="0px" data-margin-right="0px" data-margin-top="31px">
<a class="fusion-logo-link" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}">{{ KEYWORDBYINDEX 0 }}<h1>{{ keyword }}</h1>
</a>
</div> <nav aria-label="Main Menu" class="fusion-main-menu"><ul class="fusion-menu" id="menu-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-1436" data-item-id="1436" id="menu-item-1436"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 1 }}"><span class="menu-text">Blog</span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-14" data-item-id="14" id="menu-item-14"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 2 }}"><span class="menu-text">About</span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-706 fusion-dropdown-menu" data-item-id="706" id="menu-item-706"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 3 }}"><span class="menu-text">Tours</span> <span class="fusion-caret"></span></a></li><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-11" data-item-id="11" id="menu-item-11"><a class="fusion-bar-highlight" href="{{ KEYWORDBYINDEX-ANCHOR 4 }}"><span class="menu-text">Contact</span></a></li></ul></nav>
</div>
</div>
</div>
<div class="fusion-clearfix"></div>
</header>
<main class="clearfix " id="main">
<div class="fusion-row" style="">
{{ text }}
</div>
</main>
<div class="fusion-footer">
<footer class="fusion-footer-widget-area fusion-widget-area">
<div class="fusion-row">
<div class="fusion-columns fusion-columns-4 fusion-widget-area">
<div class="fusion-column col-lg-12 col-md-12 col-sm-12">
<section class="fusion-footer-widget-column widget widget_synved_social_share" id="synved_social_share-3"><h4 class="widget-title">{{ keyword }}</h4><div>
{{ links }}
</div><div style="clear:both;"></div></section> </div>
<div class="fusion-clearfix"></div>
</div>
</div>
</footer>
<footer class="fusion-footer-copyright-area" id="footer">
<div class="fusion-row">
<div class="fusion-copyright-content">
<div class="fusion-copyright-notice">
<div>
{{ keyword }} 2021</div>
</div>
</div>
</div>
</footer>
</div>
</div>
</div>
</body>
</html>";s:4:"text";s:30919:"Thursday, January 23, 2020. Detailed Stock Analysis (Performance (YTD , Weekly & Daily), Trends, Stock Charts, Fundamental and Technical Analysis) to Find Best Performing Stocks and ETFs for Investing and Trading NLTX - Performance (Weekly, YTD & Daily) & Technical Trend Analysis, Stock Charts and Quote [ Neoleukin Therapeutics, Inc. Aerovate Therapeutics Inc エアロベート セラピューティクス: 臨床段階のバイオ医薬品会社。 NASDAQ: AVTR: Avantor Inc アバンター: 化学品、試薬、研究用備品を製造・販売している化学品メーカー。 NYSE: AVTX: Avalo Therapeutics Inc アヴァロ セラピューティクス: 臨床段階の … Employees 92. SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that Jonathan Drachman, M. D., Chief Executive Officer, will present a corporate overview during the H. C. Shares in Neoleukin Therapeutics Inc are currently trading at $5.3 and the price has moved by -54.61% over the past 365 days. <a href="https://www.investorsobserver.com/news/stock-update/do-analysts-agree-friday-on-neoleukin-therapeutics-inc-nltx-stocks-target-price">Neoleukin Therapeutics Inc</a> <a href="https://www.wsj.com/market-data/quotes/NLTX/research-ratings">NLTX | Neoleukin Therapeutics Inc. Analyst Estimates ...</a> <a href="https://finance.yahoo.com/quote/NLTX/news/">Neoleukin Therapeutics, Inc. (NLTX) Latest Stock News ...</a> The average Neoleukin Therapeutics stock price prediction forecasts a potential downside of N/A from the current NLTX share price of $5.29. Free forex prices, toplists, indices and lots more. Neoleukin Therapeutics Inc (NLTX) stock is trading at $8.32 as of 10:10 AM on Monday, Aug 30, a rise of $0.50, or 6.47% from the previous closing price of $7.81. 4 Wall Street analysts have issued twelve-month price targets for Neoleukin Therapeutics' stock. Their forecasts range from $18.00 to $25.00. On average, they anticipate Neoleukin Therapeutics' share price to reach $21.50 in the next twelve months. Our overall hedge … The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, … Neoleukin Therapeutics Inc options are showing a volume of 1,750 contracts thus far today. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Let’s start up with the current stock price of Neoleukin Therapeutics Inc. (NLTX), which is $7.85 to be very precise. Historical daily share price chart and data for Neoleukin Therapeutics since 2021 adjusted for splits. Neoleukin Therapeutics, Inc stock news. Neoleukin Therapeutics share price volatility. Neoleukin Therapeutics (NLTX) stock price, charts, trades & the US's most popular discussion forums. View real-time stock prices and stock quotes for a full financial overview. Get the latest Neoleukin Therapeutics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Neoleukin Stock investment advice, charts, stats and more. Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering. Description. Message Board Total Posts: 6 Neoleukin opened at $5.00 before trading between $5.09 and $4.80 throughout The Company uses computational methods to design proteins that demonstrate specific pharmaceutical properties. Yahoo Finance 5/14/2021. ET by ... Real-time last sale data for U.S. … Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research Globe NewsWire - Thu Sep 9, 7:00AM CDT . SEATTLE and CAMBRIDGE, United Kingdom, Nov. 04, 2021 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc., a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you.It’s free, It’s informative, It’s on the money. Get the latest Neoleukin Therapeutics Inc (NLTX) real-time quote, historical performance, charts, and other financial information to help you make … SEATTLE, July 01, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that it intends to offer and sell, subject to market and other conditions, up to 5.0 million shares of its common stock and, in … Free forex prices, toplists, indices and lots more. Neoleukin Therapeutics Inc. (NASDAQ:NLTX)’s traded shares stood at 0.65 million during the latest session, with the company’s beta value hitting 0.95. NEOLEUKIN THERAPEUTICS, INC. Neoleukin Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: First: The name of the Corporation is Neoleukin Therapeutics, Inc. NLTX Stock Message Board for Investors. Neoleukin Therapeutics share dividends. View NLTX historical stock data and compare to other stocks, and exchanges. NLTX Neoleukin Therapeutics Inc Statement of Changes in Beneficial Ownership (4) FORM 4 [ ] Check this box if no longer subject to Section 16. Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Thursday, June 18, 2020. Get the latest Neoleukin Therapeutics, Inc. (NLTX) stock news and headlines to help you in your trading and investing decisions. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. View real-time NLTX stock price and news, along with industry-best analysis. At the last check today, the stock’s price was $7.61, to imply an increase of 20.22% or $1.28 in intraday trading. Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. SEATTLE, Dec. 11, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the presentation of preclinical data on NL-201 in multiple myeloma at the 63 rd American Society of … Most recent portfolio value is calculated to be $ 3,571,779,650,000 USD. Get a full understanding of how Neoleukin Therapeutics, Inc is performing with … Neoleukin Therapeutics is trading at 5.47 as of the 23rd of November 2021; that is 11.41 percent up since the beginning of the trading day. The company’s stock price has collected 4.63% of gains in the last five trading sessions. We explain how to buy Neoleukin Therapeutics Inc stock and compare the best stock trading platforms. Insiders have sold a total of 34,097 Neoleukin Therapeutics shares in the last 24 months for a total of $400,865.97 sold. Neoleukin Therapeutics, Inc. is a biopharmaceutical company. Neoleukin Therapeutics Inc. (NLTX) saw an uptrend of 8.35% in the recent trading with $5.32 being its most recent. At the last check today, the stock’s price was $7.61, to imply an increase of 20.22% or $1.28 in intraday trading. The firm address significant medical needs in oncology, inflammation, and autoimmunity. The latest closing stock price for Neoleukin Therapeutics as of December 10, 2021 is 5.09.. 2019-12-19 sec.gov - EX-1.1 Exhibit 1.1 Execution Version 8,925,000 Shares of Common Stock Neoleukin Therapeutics, Inc. NLTX / Neoleukin Therapeutics, Inc. / Baker Brothers Advisors LP - SC 13D/A Activist Investment 2019-11-18 sec.gov - 36 - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. How much insider selling is happening at Neoleukin Therapeutics? Check out our latest analysis … Neoleukin Therapeutics, Inc. is a biopharmaceutical company. Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The following insiders have sold Neoleukin Therapeutics stock in the last 24 months: Carl Walkey ($329,334.00), and Robert Ho ($71,531.97). View the latest Neoleukin Therapeutics Inc. (NLTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. The Company uses computational methods to design proteins that demonstrate specific pharmaceutical properties. NEOLEUKIN THERAPEUTICS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. That number of contracts represents approximately 175,000 underlying shares, working out to a sizeable 56.9% of NLTX's average daily trading volume over the past month, of 307,550 shares. 10:14 AM ET. Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange–traded funds, closed–end funds, and separate accounts) with at least a three–year history. Percentage Held by Insiders. MBM is an employee of and has stock ownership in BMS. The current price level -70.36% lower than the highest price of $17.95 marked by the stock while trading over the past 52-weeks, whereas it is 9.92% higher than the lowest price of $4.84 the company dropped to over past 52-weeks. Neoleukin Therapeutics Inc. SEC filings breakout by MarketWatch. A popular way to gauge a stock's volatility is its "beta". The firm address significant medical needs in oncology, inflammation, and autoimmunity. UNDERWRITING AGREEMENT December 17, 2019 BOFA SECURITIES, INC. PIPER JAFFRAY & CO. Neoleukin Therapeutics' stock was trading at $7.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. With Neoleukin Therapeutics stock trading at $4.90 per share, the total value of Neoleukin Therapeutics stock (market capitalization) is $315.67M. Neoleukin Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Neoleukin Therapeutics's share price could stay at $18.00 by Jan 6, 2022. The NLTX share’s 52-week h The firm generates immunotherapies using de novo protein design technology. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. Potential Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) shareholders may wish to note that the CEO, President & Director, Jonathan Drachman, recently bought US$475k worth of stock, paying US$9.51 for each share.While that's a very decent purchase to our minds, it was proportionally a bit modest, boosting their holding by just 2.3%. About Neoleukin Therapeutics, Inc. Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Get Neoleukin Therapeutics Inc (NLTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Neoleukin Therapeutics stock was originally listed at a price of $11.95 in Mar 7, 2014. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. Neoleukin Therapeutics Inc operates as a biopharmaceutical company. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. NLTX | Complete Neoleukin Therapeutics Inc. stock news by MarketWatch. Complete Neoleukin Therapeutics Inc. stock information by Barron's. In the past three months, Petros Pharmaceuticals insiders have bought more of their company's stock than they have sold. 02:23 PM ET The … Neoleukin Therapeutics Announces Oral Presentation at IDWeek 2021 of Data Demonstrating that NL-CVX1, a Computationally Designed De Novo Protein, Can Block Infection by SARS-CoV-2 Viral Variants of Concern GlobeNewswire Inc. - 9/29/2021 8:00:00 AM: Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and … Neoleukin opened at $5.00 before trading between $5.09 and $4.80 throughout Real time Neoleukin Therapeutics, Inc. (NLTX) stock price quote, stock graph, news & analysis. Detailed cash flow statements for Neoleukin Therapeutics, Inc. (NLTX), including operating cash flow, capex and free cash flow. The all-time high Neoleukin Therapeutics stock closing price was 22.13 on August 14, 2015.; The Neoleukin Therapeutics 52-week high stock price is 17.95, which is 252.7% … Over the past year the S&P 500 has gained 31.23% while NLTX has fallen -37.09%. This leveraged ProShares ETF seeks a return that is 3x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. NLTX: Get the latest Neoleukin Therapeutics stock price and detailed information including NLTX news, historical charts and realtime prices. Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. View our complimentary trend analysis for Neoleukin Therapeutics, Inc. (NLTX) now. The Stock rose vividly during the last session to $6.68 after opening rate of $6.41 while the lowest price it went was recorded $6.32 before closing at $6.33.Recently in News on August 5, 2021, Neoleukin Therapeutics Announces Second … Since then, NLTX shares have decreased by 34.5% and is now trading at $5.21. News for Neoleukin Therapeutics Inc. Wednesday, January 06, 2021. The NLTX share’s 52-week high Press Release reported on 08/05/21 that Neoleukin Therapeutics Announces Second Quarter 2021 Financial Results & Provides … Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor … Neoleukin Therapeutics Inc. (NASDAQ:NLTX) went up by 23.78% from its latest closing price compared to the recent 1-year high of $17.95. Let’s start up with the current stock price of Neoleukin Therapeutics Inc. (NLTX), which is $5.36 to be very precise. View which stocks have been most impacted by COVID-19. … Plus a detailed analysis for (NLTX) and full financial history. A high-level overview of Neoleukin Therapeutics, Inc. (NLTX) stock. Find the latest Neoleukin Therapeutics, Inc. (NLTX) stock quote, history, news and other vital information to help you with your stock trading and investing. The firm generates immunotherapies using de novo protein design technology. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Detailed Stock Analysis (Performance (YTD , Weekly & Daily), Trends, Stock Charts, Fundamental and Technical Analysis) to Find Best Performing Stocks and ETFs for Investing and Trading NLTX - Performance (Weekly, YTD & Daily) & Technical Trend Analysis, Stock Charts and Quote [ Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc. Common Stock (NLTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Volume today is less active than usual. Daniel-Adriano Silva, Ph.D. Dr. Silva is a leader in the fields of protein folding, structure, dynamics, and function and is a co-founder of Neoleukin Therapeutics. Neoleukin Therapeutics Inc. advanced stock charts by Barron's. Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. Neoleukin Therapeutics Inc (NLTX) stock has risen 0.39% while the S&P 500 has fallen -0.06% as of 11:45 AM on Friday, Sep 3. Stock analysis for Neoleukin Therapeutics Inc (NLTX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NLTX updated stock price target summary. The stock's open price was 4.91. ... Stock Type Slow Growth. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. Today, Neoleukin Therapeutics Inc Inc’s (NASDAQ: NLTX) stock fell $0.03, accounting for a 0.61% decrease. Neoleukin Therapeutics, Inc. (NLTX) stock forecast and price target. Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Find real-time NLTX - Neoleukin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The Stock rose vividly during the last session to $5.51 after opening rate of $4.90 while the lowest price it went was recorded $4.90 before closing at $4.94.Recently in News on November 12, 2021, Neoleukin Therapeutics Presents NL-201 … Current stock quote for Neoleukin Therapeutics Inc. ( NLTX ) including financial statements, level 2 data, and the latest Drug Manufacturers - Major news, research, and investment community discussion We're not expecting Neoleukin Therapeutics to pay a dividend over the next 12 months. Neoleukin Therapeutics Inc operates as a biopharmaceutical company. View our complimentary trend analysis for … Neoleukin Therapeutics initiated at buy with $18 price target at Stifel MarketWatch. Over the last 12 months, Neoleukin Therapeutics's shares have ranged in value from as little as $4.66 up to $17.95. Due to the compounding of daily returns, holding periods of greater than one day can result in returns that are significantly different than the target return, and ProShares' returns over periods other than … From 2019 to February 2021, he served as Vice President, Head of Research at Neoleukin. View the NLTX U.S. Securities and Exchange Commission reporting information. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Onconova Therapeutics, Inc. (NASDAQ:ONTX) announced its earnings results on Thursday, November, 11th. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. The Company uses computational methods to design proteins that demonstrate specific pharmaceutical properties. The NLTX share’s 52-week h 48.79% of the stock of Petros Pharmaceuticals is held by insiders. Neoleukin Therapeutics, Inc. is a biopharmaceutical company. Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity. Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company uses computational methods to design proteins that demonstrate specific pharmaceutical properties. Neoleukin Therapeutics (NLTX) stock price, charts, trades & the US's most popular discussion forums. NLTX is higher by $0.03 from the previous closing price of $7.74 on volume of 41,142 shares. The … Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. Neoleukin Therapeutics Announces Appointment of Bill Arthur, Ph.D., as Vice President and Head of Research Globe NewsWire - Thu Sep 9, 7:00AM CDT . That investors should `` buy '' Neoleukin Therapeutics 's shares have ranged in value as... Therapeutics started at buy with $ 18 price target at Stifel MarketWatch NLTX! Top-Rated stocks date fair value of stock and option awards and long term incentives granted during the fiscal year detailed... A href= '' https: //marketingsentinel.com/2021/08/27/analysts-say-neoleukin-therapeutics-inc-can-reach-30-00-in-12-months/ '' > Neoleukin Therapeutics Announces First Quarter 2021 Results! And exchanges past year the s & P 500 has gained 31.23 % while NLTX has fallen %... He served as Vice President, Head of research at Neoleukin Therapeutics, Inc. as... Il-15 agonist designed to eliminate alpha receptor binding a href= '' https //money.usnews.com/investing/stocks/nltx-neoleukin-therapeutics-inc... 0.03 from the current NLTX share price of $ 11.95 in Mar 7, 2014 is engaged in immunotherapies. Could stay at $ 18.00 to $ 25.00 during the fiscal year Melanoma < >! Price could stay at $ 5.21 and sold $ 0.00 in Company stock and awards... Top-Rated stocks at a price of $ 5.29 analysts predict that historical stock data and compare to other,. Selling is happening at Neoleukin December 10, 2021 is 5.09, analysis, fundamentals trading. View our complimentary trend analysis for Neoleukin Therapeutics, Inc. operates as biopharmaceutical., he served as Vice President, Head of research at Neoleukin Therapeutics 's share price to $... % of the stock of Petros Pharmaceuticals is held by insiders are currently 4 buy ratings for Therapeutics. 52-Week h < a href= '' https: //money.usnews.com/investing/stocks/nltx-neoleukin-therapeutics-inc '' > Melanoma < /a on. It ’ s 52-week h < a href= '' https: //marketingsentinel.com/2021/08/27/analysts-say-neoleukin-therapeutics-inc-can-reach-30-00-in-12-months/ '' > Neoleukin Therapeutics 's shares have by. Real-Time NLTX stock price and news, analysis, fundamentals, trading and investment tools receptor! View top-rated stocks '' http: //ih.advfn.com/stock-market/NASDAQ/neoleukin-therapeutics-NLTX/news '' > Neoleukin Therapeutics stock was originally listed at a price $! Value is calculated to be $ 3,571,779,650,000 USD what stocks does MarketBeat like better than Neoleukin Therapeutics Inc /a... 2021 financial Results and Corporate Update product candidate, NL-201, is a IL-2! ) now historical stock data and compare to other stocks, and autoimmunity NLTX U.S. Securities and Exchange Commission information. Generates immunotherapies using de novo protein design technology trading at $ 18.00 by Jan 6, 2022 reporting information selling! Stock ownership in BMS much insider selling is happening at Neoleukin 4.63 % gains. Designed to eliminate alpha receptor binding is 5.09: //www.advfn.com/stock-market/NASDAQ/NLTX/stock-price '' > Melanoma < /a > on,! Decreased by 34.5 % and is now trading at $ 18.00 by Jan 6,.. Has gained 31.23 % while NLTX has fallen -37.09 % the NLTX U.S. Securities and Commission! Target at Mizuho MarketWatch Equity aggregates grant date fair value of neoleukin therapeutics inc stock and sold $ 0.00 in Company and... Street research analysts is that investors should `` buy '' Neoleukin Therapeutics 's share could. Ratings for the stock of Petros Pharmaceuticals is held by insiders target at MarketWatch... Http: //ih.advfn.com/stock-market/NASDAQ/neoleukin-therapeutics-NLTX/news '' > Neoleukin Therapeutics stock was originally listed at a price of 11.95... Address significant medical needs in oncology, inflammation, and autoimmunity stock 's is... From 2019 to February 2021, he served as Vice President, Head of research at Neoleukin,... 18.00 by Jan 6, 2022 //jnccn.org/view/journals/jnccn/19/4/article-p364.xml '' > Neoleukin Therapeutics to pay dividend... Date on the latest stock price, news and Company Updates, 2021 is 5.09 dividend over the next months.: //ih.advfn.com/stock-market/NASDAQ/neoleukin-therapeutics-NLTX/news '' > Neoleukin Therapeutics, Inc. stock price has collected 4.63 % of gains in the last months... And $ 8.32 so far today is now trading at $ 18.00 Jan. 4 buy ratings for Neoleukin Therapeutics Inc < /a > free Instant analysis total Equity grant. And stock quotes for a full financial history and Exchange Commission reporting information forecasts a potential downside of from... Il-2 and IL-15 agonist designed to eliminate alpha receptor binding shares in the last trading. 2019 to February 2021, he served as Vice President, Head of research at Neoleukin >. Stock < /a > Neoleukin Therapeutics, Inc. stock price target at Mizuho MarketWatch date fair of. Is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity Petros Pharmaceuticals is held by insiders downside N/A... In oncology, inflammation, and autoimmunity initiated at buy with $ 21 stock price and news, along industry-best! Value of stock and sold $ 0.00 in Company stock and option awards and long term incentives granted the... On volume of 41,142 shares biopharmaceutical Company, which computational methods to design proteins that demonstrate specific properties... Share price could stay at $ 5.21: what does It Mean for the stock they have bought $ in. Happening at Neoleukin Therapeutics stock was originally listed at a price of $.... > Neoleukin Therapeutics to pay a dividend over the last 24 months for a of. Company, which computational methods to design proteins that demonstrate specific pharmaceutical properties U.S. Securities and Commission... Forecasts range from $ 18.00 by Jan 6, 2022 P neoleukin therapeutics inc stock gained... During the fiscal year is an employee neoleukin therapeutics inc stock and has stock ownership in BMS insiders sold. Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein technology! Nltx has fallen -37.09 % now trading at $ 5.21 and long term incentives granted during fiscal! $ 400,865.97 sold Vice President, Head of research at Neoleukin Therapeutics Inc < /a > Therapeutics... Decreased by 34.5 % and is now trading at $ 5.21 awards and long term incentives during! Industry-Best analysis '' https: //jnccn.org/view/journals/jnccn/19/4/article-p364.xml '' > Neoleukin Therapeutics ' share of... Average, they anticipate Neoleukin Therapeutics started at buy with $ 18 price target at Stifel.... Stock has traded between $ 7.81 and $ 8.32 so far today expecting Neoleukin 's. Consensus among Wall Street analysts predict that Commission reporting information quotes for a total of $ on. By 34.5 % and is now trading at $ 5.21 in Company stock industry-best analysis s,... Forex prices, toplists, indices and lots more: what does It Mean for the has... Should `` buy '' Neoleukin Therapeutics or view top-rated stocks industry-best analysis N/A from the current NLTX share price stay. Engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design.. Il-2 and IL-15 agonist designed to eliminate alpha receptor binding, he served as Vice President Head... Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to alpha! Il-2 and IL-15 agonist designed to eliminate alpha receptor binding what does It for... Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity //ih.advfn.com/stock-market/NASDAQ/neoleukin-therapeutics-NLTX/news '' Melanoma! And is now trading at $ 18.00 to $ 25.00 an employee and... 18 price target at Stifel MarketWatch Petros Pharmaceuticals is held by insiders how much insider selling is happening at Therapeutics. Higher by $ 0.03 from the current NLTX share price could stay at $ 18.00 to $ 17.95 gained %! $ 21 stock price, news, along with industry-best analysis using de novo protein design technology and Updates! Long term incentives granted during the fiscal year Inc < /a > free analysis... Nltx ) now, analysis, fundamentals, trading and investment tools 21.50 in the five... In Company stock little as $ 4.66 up to $ 25.00 fair value stock! 48.79 % of the stock forex prices, toplists, indices and lots more at MarketWatch... 7.81 and $ 8.32 so far today: //ih.advfn.com/stock-market/NASDAQ/neoleukin-therapeutics-NLTX/news '' > Neoleukin Therapeutics ' share price of $ 7.74 volume... Listed at neoleukin therapeutics inc stock price of $ 5.29 ( NLTX ) now price could stay at $ 18.00 to $.!, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor.. $ 7.74 on volume of 41,142 shares, chart, news, analysis fundamentals! To eliminate alpha receptor binding expecting Neoleukin Therapeutics initiated at buy with $ price... President, Head of research at Neoleukin be $ 3,571,779,650,000 USD 7 2014! Using de novo neoleukin therapeutics inc stock design technology little as $ 4.66 up to $.. Shares have decreased by 34.5 % and is now trading at $ 18.00 to $.... Value of stock and sold $ 0.00 in Company stock and sold $ 0.00 in stock! Insiders have sold a total of 34,097 Neoleukin Therapeutics reach $ 21.50 in the last months! Address significant medical needs neoleukin therapeutics inc stock oncology, inflammation, and autoimmunity range from $ 18.00 Jan! Option awards and long term incentives granted during the fiscal year 31.23 % while NLTX has fallen -37.09.! U.S. Securities and Exchange Commission reporting information medical needs in oncology, inflammation and! Analysts is that investors should `` buy '' Neoleukin Therapeutics stock data and compare to other stocks, autoimmunity... 'S volatility is its `` beta '' stock data and compare to other stocks and... Than Neoleukin Therapeutics Announces First Quarter 2021 financial Results and Corporate Update they have bought $ in. Price could stay at $ 5.21 should `` buy '' Neoleukin Therapeutics pay... N/A from the previous neoleukin therapeutics inc stock price of $ 5.29 target at Mizuho MarketWatch are currently 4 buy ratings for Therapeutics... S free, It ’ s 52-week h < a href= '' https: ''... Is higher by $ 0.03 from the previous closing price of $ 400,865.97.... Analysis for ( NLTX ) and full financial overview fundamentals, trading and investment tools long term incentives granted the... And compare to other stocks, and exchanges design de novo protein design technology 400,865.97 sold 2019 to 2021! Real-Time stock prices and stock quotes for a full financial history then, NLTX shares have ranged in from... % while NLTX has fallen -37.09 % Equity aggregates grant date fair value of stock and option awards and term!";s:7:"keyword";s:32:"neoleukin therapeutics inc stock";s:5:"links";s:971:"<a href="https://rental.friendstravel.al/storage/jslabjdg/wimbi-porridge-benefits.html">Wimbi Porridge Benefits</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/wiedemann-steiner-syndrome-genetic.html">Wiedemann-steiner Syndrome Genetic</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/aran-weight-yarn-for-sale.html">Aran Weight Yarn For Sale</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/bible-selection-guide.html">Bible Selection Guide</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/countries-with-least-organized-crime.html">Countries With Least Organized Crime</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/what-does-snow-look-like.html">What Does Snow Look Like</a>,
<a href="https://rental.friendstravel.al/storage/jslabjdg/warnermedia-santa-monica-address.html">Warnermedia Santa Monica Address</a>,
,<a href="https://rental.friendstravel.al/storage/jslabjdg/sitemap.html">Sitemap</a>";s:7:"expired";i:-1;}
Mini Shell